XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 02, 2022
Apr. 03, 2021
Cash flows from operating activities:    
Net income $ 46,595 $ 53,383
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 9,134 8,493
Stock-based compensation 10,869 12,708
Loss on disposal of equipment, intangibles and other assets 215 29
Provision for credit losses 495 49
Changes in operating assets and liabilities:    
Decrease in accounts receivable 402 6,823
Increase in inventories (12,357) (915)
(Increase) decrease in other current assets (1,432) 16,326
Increase in lease receivable, net (236) (919)
Increase in deferred costs and other contract assets (14,889) (1,307)
Increase in other non-current assets (50) (77)
Increase (decrease) in accounts payable 9,179 (599)
Decrease in accrued compensation (20,698) (23,343)
Decrease in accrued liabilities (3,536) (5,813)
Increase (decrease) in income tax payable 1,312 (303)
Decrease in deferred revenue and other contract-related liabilities (1,781) (5,308)
(Decrease) increase in other non-current liabilities (64) 33
Net cash provided by operating activities 23,158 59,260
Cash flows from investing activities:    
Purchases of property and equipment, net (20,479) (8,903)
Increase in intangible assets (2,460) (1,572)
Other strategic investing activities 850 0
Net cash used in investing activities (23,789) (10,475)
Cash flows from financing activities:    
Proceeds from issuance of common stock 3,153 5,756
Payroll tax withholdings on behalf of employees for vested equity awards (25,376) (16,691)
Repurchases of common stock 0 (128,917)
Net cash used in financing activities (22,223) (139,852)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (2,505) 279
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (25,359) (90,788)
Cash, cash equivalents and restricted cash at end of period 720,108 551,992
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 723,019 $ 554,216